Two unusual clinical presentations of juvenile xanthogranuloma (JXG), the most common non-Langerhans cell histiocytosis, are described: a flat ‘plaque-like’ and a ‘paired’ form. This report confirms the great variability of JXG. Besides representing a dermatological curiosity, the recognition of these atypical forms of presentation should facilitate the clinical diagnosis of the disorder.

Hernandez-Martin A, Baselga E, Drolet BA, Esterly NB: Juvenile xanthogranuloma. J Am Acad Dermatol 1997;36:355–367.
Winkelmann RK: Cutaneous syndromes of non-X histiocytosis: A review of the macrophage-histiocyte diseases of the skin. Arch Dermatol 1981;117:667–672.
Gianotti F, Caputo R: Histiocytic syndromes: A review. J Am Acad Dermatol 1985;13: 383–404.
Tanz WS, Schwartz RA, Janniger CK: Juvenile xanthogranuloma. Cutis 1994;54:241–245.
Burgdorf WHC, Zelger B: The non-Langerhans’ cell histiocytoses in childhood. Cutis 1996;58:201–207.
Caputo R, Grimalt R, Gelmetti C, Cottoni F: Unusual aspects of juvenile xanthogranuloma. J Am Acad Dermatol 1993;29:868–870.
Campbell L, McTigue MK, Esterly N, Rosenbaum M: Giant juvenile xanthogranuloma. Arch Dermatol 1988;124:1723–1724.
Labbe L, Bioulac-Sage P, Taïeb A: Xanthogranulome juvénile: une forme géante congénitale. Ann Dermatol Vénéréol 1995;122: 678–681.
Sànchez Yus E, Requena L, Villegas C, Valle P: Subcutaneous juvenile xanthogranuloma. J Cutan Pathol 1995;22:460–465.
Satow SJ, Zee S, Dawson KH, Gown AM, Oda D, Worthington P: Juvenile xanthogranuloma of the tongue. J Am Acad Dermatol 1995; 33:376–379.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.